Tag #Cell Therapy

Showing 1 to 6 of 6 results

forbes.com

🌐 90% Global Worthiness

Aug 31, 22:15

Multiply Labs and Universal Robots Partner to Automate Cell Therapy Production

Multiply Labs, a San Francisco startup, partnered with Universal Robots to automate cell therapy production, aiming to reduce costs and increase manufacturing scale of these expensive and complex treatments.

Multiply Labs and Universal Robots Partner to Automate Cell Therapy Production

Multiply Labs, a San Francisco startup, partnered with Universal Robots to automate cell therapy production, aiming to reduce costs and increase manufacturing scale of these expensive and complex treatments.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary impact of automating cell therapy production using robotic clusters?

Automating cell therapy production with robotic clusters significantly reduces costs (up to 74% per dose) and increases efficiency (up to 100 times more patient doses per square foot of cleanroom). This expands access to these life-saving treatments for more patients.

welt.de

🌐 75% Global Worthiness

Jul 9, 10:12

Cancer Research: Challenges and Advancements in Immunotherapy

A German podcast episode, "Aha! Ten Minutes of Everyday Knowledge," features Professor Stefan Fröhling discussing cancer research, highlighting challenges in rare cancers, the potential of immunotherapies (currently effective in 20% of patients), and the need for more personalized treatment strategi...

Cancer Research: Challenges and Advancements in Immunotherapy

A German podcast episode, "Aha! Ten Minutes of Everyday Knowledge," features Professor Stefan Fröhling discussing cancer research, highlighting challenges in rare cancers, the potential of immunotherapies (currently effective in 20% of patients), and the need for more personalized treatment strategi...

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the most significant challenges in cancer research, and how are these challenges impacting treatment effectiveness?

Aha! Ten Minutes of Everyday Knowledge" podcast episode discusses cancer research challenges and advancements. Professor Stefan Fröhling highlights research gaps in rare cancers due to limited prevalence hindering systematic studies, while emphasizing immunotherapy and cell therapy as promising treatments with current success rates capped at 20 percent. Late diagnoses and drug resistance remain significant obstacles.

t24.com.tr

🌐 85% Global Worthiness

Mar 30, 04:11

ATTD 2025: Diabetes Technology Advancements and Access Concerns

The ATTD 2025 conference in Amsterdam (March 19-22) showcased advancements in diabetes treatments and technology, including stem-cell based beta-cell replacement therapies and GLP-1/harmine combinations for beta-cell regeneration, alongside concerns about unequal access to these technologies and the...

ATTD 2025: Diabetes Technology Advancements and Access Concerns

The ATTD 2025 conference in Amsterdam (March 19-22) showcased advancements in diabetes treatments and technology, including stem-cell based beta-cell replacement therapies and GLP-1/harmine combinations for beta-cell regeneration, alongside concerns about unequal access to these technologies and the...

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do socioeconomic factors and unequal access to technology affect diabetes management, and what are the broader implications of this disparity?

The conference highlighted advancements in cell therapy for Type 1 diabetes, with companies like Vertex leading research into beta-cell replacement using stem cells (VX-880 and VX-264). While promising, these treatments are not yet widely available, with challenges like the need for immunosuppressants. Other advancements included GLP-1 and harmine combinations for beta-cell regeneration, showing a 700% increase in regeneration.

welt.de

🌐 75% Global Worthiness

Aug 29, 16:18

Mecklenburg-Vorpommern Funds €8.2 Million for Cell and Gene Therapy Platform

The state of Mecklenburg-Vorpommern in Germany is providing €8.2 million in funding from the European Regional Development Fund (EFRE) to support the development of a cell and gene therapy platform by a research consortium involving Miltenyi Biotec, RoweMed AG, and the University of Rostock.

Mecklenburg-Vorpommern Funds €8.2 Million for Cell and Gene Therapy Platform

The state of Mecklenburg-Vorpommern in Germany is providing €8.2 million in funding from the European Regional Development Fund (EFRE) to support the development of a cell and gene therapy platform by a research consortium involving Miltenyi Biotec, RoweMed AG, and the University of Rostock.

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the main purpose of the €8.2 million funding provided by Mecklenburg-Vorpommern?

The funding supports the development of an automated cell and gene therapy platform to optimize the production of therapeutic cells used in treating severe diseases. This platform aims to improve the efficiency and scalability of manufacturing these advanced therapies.

forbes.com

🌐 85% Global Worthiness

May 13, 16:12

Somite AI Secures \$47 Million to Revolutionize Human Cell Production with AI

Somite AI, a biotech startup, raised \$47 million in Series A funding to develop DeltaStem, an AI platform aiming to revolutionize human cell production for therapeutic applications, addressing challenges in purity, scalability, and reproducibility of stem cell differentiation.

Somite AI Secures \$47 Million to Revolutionize Human Cell Production with AI

Somite AI, a biotech startup, raised \$47 million in Series A funding to develop DeltaStem, an AI platform aiming to revolutionize human cell production for therapeutic applications, addressing challenges in purity, scalability, and reproducibility of stem cell differentiation.

Progress

16% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of Somite AI's \$47 million Series A funding round for the field of regenerative medicine?

Somite AI, a startup developing AI-driven stem cell technology, secured \$47 million in Series A funding, bringing its total funding to approximately \$60 million. This round was led by Khosla Ventures and included participation from several prominent investors. The funding will support Somite's efforts to revolutionize human cell production using its AI platform, DeltaStem.

theguardian.com

🌐 85% Global Worthiness

Mar 17, 13:15

AstraZeneca's $1 Billion Acquisition of EsoBiotec Expands Cancer Immunotherapy Portfolio

AstraZeneca, Britain's largest listed pharmaceutical company, acquired Belgian biotech EsoBiotec for $1 billion to expand its cancer immunotherapy portfolio, offering faster and more cost-effective treatments; this follows other recent acquisitions and positive drug development news.

AstraZeneca's $1 Billion Acquisition of EsoBiotec Expands Cancer Immunotherapy Portfolio

AstraZeneca, Britain's largest listed pharmaceutical company, acquired Belgian biotech EsoBiotec for $1 billion to expand its cancer immunotherapy portfolio, offering faster and more cost-effective treatments; this follows other recent acquisitions and positive drug development news.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of AstraZeneca's $1 billion acquisition of EsoBiotec for the global cancer treatment market?

AstraZeneca purchased EsoBiotec, a Belgian biotech company specializing in cancer immunotherapies, for $1 billion. This acquisition is part of AstraZeneca's strategy to expand its global operations and enhance its cancer treatment portfolio. EsoBiotec's innovative approach offers faster and more cost-effective cell therapies.

Showing 1 to 6 of 6 results